See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot3,994▼ 0.75%WTI102.37▼ 0.87%
← 0A91 page
XStocksXray
Market X-Ray report · 23 October 2026

Lemonade, Inc. (0A91)

London Exchange · UK · prices in USD · close of 23 Oct 2026

Key indicators

Last closeUSD 45.50
52-week range42.42 – 99.77
Return, 1 month / 3 months+1.4% / −26.0%
Return, 1 year / 3 years– / –
TrendBelow its 200-day average
RSI (14)45
Volatility (1 year)70.2%
Worst drawdown (1 year)-55.0%
Average daily value traded0.22M USD
Dividend yield–

Market X-Ray price-based

16/ 100 · Medium confidence · ahead of 7% of stocks on this exchange
Trend11
Momentum10
Stability (higher is calmer)15
Liquidity38
Income–

Five-year price chart navy: price · brown: 200-day average

40.0054.7669.5384.2999.062025-122026-022026-052026-082026-10

About the company

Lemonade is an insurance company that sells renters, homeowners, pet and life cover to individuals, mostly in the United States. It handles policies and claims through its mobile app and website, using artificial intelligence and chatbots to process many claims quickly. The company is based in New York and markets itself around a fixed-fee model, with unused premiums directed to charities chosen by customers.

Lemonade, Inc. trades under the code 0A91 on the London Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Lemonade, Inc. (0A91) trades on the London Exchange in UK. It last closed at USD 45.50 on 23 October 2026.

Its price-based Market X-Ray is 16 out of 100 (a weak price profile), ranking 3,535 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Lemonade, Inc. (0A91)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend11 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-23.1%
From 52-week high-52.6%
Momentum10 · WeakLagging most stocks on this exchange.
3-month return-26.0%
6-month return-29.7%
12-month return, skipping the last month–
Stability (higher is calmer)15 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)70.2%
Worst drawdown, 1 year (smaller is calmer)-55.0%
Liquidity38 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.22M USD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+4.0%
1 month+1.4%
3 months−26.0%
6 months−29.7%
1 year–
3 years–
5 years–

Signals

50-day / 200-day average48.53 / 59.18
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.40

Technical summary

DailyBearish3 bullish · 4 neutral · 8 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 6 bearish
MonthlyStrongly bearish0 bullish · 0 neutral · 1 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 25 Oct 2026